The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 23, 2026
Filed:
Apr. 06, 2021
Applicant:
Ucb Biopharma Srl, Brussels, BE;
Inventors:
Prafulkumar Tulshibhai Chovatia, Abingdon, GB;
Anne Marie Foley, Slough, GB;
Martin Clive Hutchings, Slough, GB;
James Andrew Johnson, Slough, GB;
Fabien Claude Lecomte, Slough, GB;
Nathaniel Julius Thomas Monck, Abingdon, GB;
James Thomas Reuberson, Slough, GB;
Adam Peter Smalley, Slough, GB;
Darshan Gunvant Vaidya, Abingdon, GB;
Assignee:
UCB BIOPHARMA SRL, Brussels, BE;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 413/14 (2006.01); A61K 45/06 (2006.01); C07D 235/24 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 413/12 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); A61K 45/06 (2013.01); C07D 235/24 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 413/12 (2013.01); C07D 471/04 (2013.01);
Abstract
A series of substituted 4,4-difluorocyclohexyl derivatives as defined herein, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.